Vol. 10. Núm. 44.
Páginas 2934-2941 (Noviembre 2009)

Actualización
Muerte súbita

M. Rodríguez-MañeroA. Macías GallegoI. García-Bolao
Doi : https://10.1016/S0304-5412(09)72773-8
Opciones

Identifíquese

¿Aún no es suscriptor de la revista?

Comprar el acceso al artículo

Comprando el artículo el pdf del mismo podrá ser descargado

Teléfono para incidencias

De lunes a viernes de 9h a 18h (GMT+1) excepto los meses de julio y agosto que será de 9 a 15h

Llamadas desde España 932 415 960
Llamadas desde fuera de España +34 932 415 960
Bibliografía
[1.]
Sen-Chowdhry, W.J. McKenna.
Sudden cardiac death in the young: a strategy by targeted evaluation.
Cardiology, (2006), 105 pp. 196-206
[2.]
E.G. Nabel.
Cardiovascular disease.
N Engl J Med, (2003), 349 pp. 60-72
[3.]
D.P. Zipes.
Sudden cardiac death.
Circulation, (1998), 98 pp. 233-251
[4.]
R.J. Myerburg, R. Mitrani, A. Interian Jr, A. Castellanos.
Interpretation of outcomes of antiarrhythmic clinical trials: Design features and population impact.
Circulation, (1998), 97 pp. 1514-1521
[5.]
W.B. Kannel, H.E. Thomas Jr.
Sudden coronary death: The Framingham Study.
Ann NY Acad Sci, (1982), 382 pp. 3-21
[6.]
M. Montagnana.
Sudden cardiac death: prevalence, pathogenesis and prevention.
Ann Med, (2008), 40 pp. 360-375
[7.]
M. Luu, W.G. Stevenson, L.W. Stevenson, K. Baron, J. Walden.
Diverse mechanisms of unexpected cardiac arrest in advanced heart failure.
Circulation, (1989), 80 pp. 1675-1680
[8.]
A.L. Wit, M.J. Janse.
Experimental models of ventricular tachycardia and fibrillation caused by ischemia and infarction.
Circulation, (1992), 85 pp. I-32-I-42
[9.]
H.-R. Arntz, S.N. Willich, C. Schreiber, T. Bruggemann, R. Stern.
Diurnal, weekly and seasonal variation of sudden death.
Eur Heart Journal, (2000), 21 pp. 315-320
[10.]
R.A. Kloner.
Natural and unnatural triggers of myocardial infarction.
Prog Cardiovacular Dis, (2006), 48 pp. 285-300
[11.]
M.D. Meisner, M. Akhar, M.H. Lehmann.
Nonischemic suden tachyarrytmic death in atherosclerotic heart disease.
Circulation, (1991), 84 pp. 905-912
[12.]
M.J. Davies.
Anatomic features in victims of sudden coronary death: Coronary artery artery pathology.
Circulation, (1992), 85 pp. 19-24
[13.]
M. Turakhia, Z.H. Tseng.
Sudden cardiac death: epidemiology, mechanism, and therapy.
Curr Probl Cardiol, (2007), 32 pp. 501-546
[14.]
C.J. Berger, J.M. Murabito, J.C. Evans, K.M. Anderson, D. Levy.
Prognosis after first myocardial infartion. Comparison of non q-wave myocardial infarction in the Framingham Heart Study.
JAMA, (1992), 268 pp. 1545-1551
[15.]
B. Fagerberg, MERIT-HF Study Group.
Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF).
Lancet, (1999), 353 pp. 2001-2007
[16.]
J. De Sutter, D. De Bacquer, L. Jordaens.
Intensive lipid lowering therapy and ventricular arrhytmias in patients with coronary artery disease and internal cardioverter desfibrillator.
Heart Rhythm Society Scientific Sessions, MA, (2006),
[17.]
A.J. Moss, W. Zareba, W.J. Hall, H. Klein, D.J. Wilber, D.S. Cannom, et al.
Prophylactic implantation of a desfibrillator in patients with myocardial infarction and reduced ejection fraction.
N Engl J Med, (2002), 346 pp. 877-883
[18.]
R.D. Berger, E.K. Kasper, K.L. Baughman, E. Marban.
Beat to beat QT interval variability: novel evidence for repolarization lability in ischemic and nonischemic dilated cardiomyopapthy.
Circulation, (1997), 96 pp. 1557-1565
[19.]
O. Oseroff, E. Retyk, A. Bochoeyer.
Subanalyses of secondary prevention implantable cardioverter-desfibrillator trials: antiarrhymics versus implantable desfibrillators (AVID), Canadian Implantable Desfibrillator Study (CIDS), and Cardiac Arrest Study Hamburg (CASH).
Curr Opin Cardiol, (2004), pp. 26-30
[20.]
K.A. Ellenbogen, J.H. Levine, R.D. Berger, J.P. Daubert, S.L. Winters, E. Greenstein, et al.
Are implantable cardioverter desfibrillator shocks a surrogate for sudden cardiac death in patients with nonischemic cardiomyopathy?.
Circulation, (2006), 113 pp. 776-782
[21.]
D.P. Zipes, A.J. Camm, M. Borggrefe, A.E. Buxton, B. Chaitman, M. Fromer, et al.
ACC/AHA/ESC 2006. Guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death-executive summary.
Eur Heart J, (2006), 27 pp. 2099-2140
[22.]
P.M. Elliot, P. Spirito.
Prevention of hypertrophic cardiomyopathyrelated deaths: theory and practise.
Heart, (2008), 94 pp. 1269-1275
[23.]
B.J. Maron, W.C. Robert, S.E. Epstein.
Sudden death in hypertrophic cardiomyopathy: a profile of 78 patients.
Circulation, (1982), 65 pp. 1388-1394
[24.]
P.M. Elliott, J.R. Gimeno Blanes, N.G. Mahon, J.D. Poloniecki, W.J. McKenna.
Relation between severity of left ventricular hypertrophy and prognosis in patients with hypertrophic cardiomyopathy.
[25.]
P.M. Elliot, J. Poloniecki, S. Dickie.
Sudden death in hypertrophic cardiomyopathy: identification of high risk patients.
J Am Coll Cardiol, (2000), 36 pp. 2212-2218
[26.]
D. Corrado, G. Fontaine, F.I. Marcus, W.J. McKenna, A. Nava, G. Thiene, et al.
Arrhythmogenic right ventricular dysplasia/cariomyopathy: need for an international registry. Study Group on arrhytmogenic right ventricular dysplasia/cardiomyopathy of the working group on myocardial and pericardial disease and arrrhytmias of the European Society of Cardiology and of the Scientific Council on Cardiomyopathies of the World Heart Federation.
Circulation, (2000), 101 pp. E101-E106
[27.]
D. Dalal, K. Nasir, C. Bomma, K. Prakasa, H. Tandri, J. Piccini, et al.
Arrythmogenic right ventricular dysplasia: a United States experience.
Circulation, (2005), 112 pp. 3823-3832
[28.]
J.L. Merino.
Arritmología clínica.
Momento Médico. Iberoamérica, (2003),
[29.]
E.H. Locati, W. Zarabea.
Age and sex related differences in clinical manifestations in patients with congenital long QT syndrome: findings from the International LQTS Registry.
Circulation, (1998), 97 pp. 2237-2244
[30.]
A.J. Moss, W. Zarabea, W.J. Hall, P.J. Schwartz, R.S. Crampton, J. Benhorin, et al.
Effectiveness and limitations of beta-bloquer therapy in congenital long- QT syndrome.
Circulation, (2000), 101 pp. 616-623
[31.]
S.G. Priori, C. Napolitano, L. Diehl.
Dispersion of the QT interval. A marker of therapeutic efficacy in the idiopatic long QT syndrome.
Circulation, (1994), 89 pp. 45-50
[32.]
R. Brugada, K. Hong, J.M. Cordeiro, R. Dummaine.
Short QT syndrome.
CMAJ, (2005), 173 pp. 1349-1354
[33.]
P. Brugada, J. Brugada.
Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. A multicenter report.
J Am Coll Cardiol, (1992), 20 pp. 1391-1396
[34.]
A.A. Wilde, C. Antzelevitch, M. Borggrefe, J. Brugada, R. Brugada, P. Brugada, et al.
Proposed criteria for the Brugada syndrome.
Eur Heart J, (2002), 23 pp. 1648-1654
[35.]
C. Antzelevitch, P. Brugada, M. Borggrefe, J. Brugada, R. Brugada, D. Corrado, et al.
Brugada syndrome: report of the Second Consensus Conference: Endorsed by the Heart Rhythm Society and the European Heart Rhythm Association.
Circulation, (2005), 111 pp. 659-670
[36.]
J. Brugada, R. Brugada, P. Brugada.
Determinants of sudden cardiac death in individuals with the electrocardiographic pattern of Brugada syndrome and no previous cardiac arrest.
Circulation, (2003), 108 pp. 3092-3096
[37.]
P. Brugada, R. Brugada, J. Brugada.
Should patients with an asyntomatic Brugada electrocardiogram undergo pharmacological and electrophysiolgical testing?.
Circulation, (2006), 114 pp. 2317-2324
[38.]
G. Katz, M. Arad.
Catecholaminergic polymorphic ventricular tachycardia from beside to bench and beyond.
Curr Probl Cardiol, (2009), 34 pp. 9-43
Copyright © 2009. Elsevier España, S.L.. Todos los derechos reservados